“Close the care gap” campaign
The POSITIVE study closes a unmet medical need by demonstrating that young women with hormone-sensitive early breast cancer can pause their endocrine treatment to attempt pregnancy without additional risk of recurrence in the short term. Media alert available here.
We plan to follow-up the study participants until 2029 to assess breast cancer recurrence risk over time. THANK YOU for supporting the continuation of the POSITIVE study. We owe an answer to young breast cancer patients who wish a baby.